Koninklijke Philips N.V. (PHIA.AS)
EUR 24.19
(1.51%)
EUR 24.19
(1.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.82 Billion EUR | -17.2% |
| 2022 | 7.02 Billion EUR | 50.32% |
| 2021 | 4.67 Billion EUR | 26.11% |
| 2020 | 3.7 Billion EUR | -7.81% |
| 2019 | 4.02 Billion EUR | 28.38% |
| 2018 | 3.13 Billion EUR | 12.82% |
| 2017 | 2.77 Billion EUR | -15.13% |
| 2016 | 3.27 Billion EUR | -18.08% |
| 2015 | 3.99 Billion EUR | 79.02% |
| 2014 | 2.23 Billion EUR | 55.36% |
| 2013 | 1.43 Billion EUR | 105.14% |
| 2012 | 700 Million EUR | -1.82% |
| 2011 | 713 Million EUR | 160.68% |
| 2010 | -1.17 Billion EUR | -887.39% |
| 2009 | -119 Million EUR | -120.95% |
| 2008 | 568 Million EUR | 110.88% |
| 2007 | -5.22 Billion EUR | -142.33% |
| 2006 | -2.15 Billion EUR | -167.43% |
| 2005 | -805.47 Million EUR | -589.64% |
| 2004 | 164.5 Million EUR | -94.12% |
| 2003 | 2.79 Billion EUR | -46.75% |
| 2002 | 5.25 Billion EUR | -24.78% |
| 2001 | 6.98 Billion EUR | 137.21% |
| 2000 | 2.94 Billion EUR | 198.85% |
| 1999 | 985.83 Million EUR | 133.43% |
| 1998 | -2.94 Billion EUR | -214.84% |
| 1997 | 2.56 Billion EUR | -50.29% |
| 1996 | 5.16 Billion EUR | 27.42% |
| 1995 | 4.05 Billion EUR | -30.68% |
| 1994 | 5.84 Billion EUR | -9.35% |
| 1993 | 6.45 Billion EUR | -41.75% |
| 1992 | 11.07 Billion EUR | 108.31% |
| 1991 | 5.31 Billion EUR | -18.18% |
| 1990 | 6.49 Billion EUR | -39.81% |
| 1989 | 10.79 Billion EUR | -1.86% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -1.8 Billion EUR | -127.98% |
| 2024 Q1 | 1.87 Billion EUR | -67.41% |
| 2024 Q2 | 6.45 Billion EUR | 245.03% |
| 2023 Q2 | 7.25 Billion EUR | 513.36% |
| 2023 Q4 | 5.74 Billion EUR | 493.39% |
| 2023 FY | 5.82 Billion EUR | -17.2% |
| 2023 Q3 | 968 Million EUR | -86.66% |
| 2023 Q1 | 1.18 Billion EUR | -83.17% |
| 2022 Q2 | 6.74 Billion EUR | 192.54% |
| 2022 FY | 7.02 Billion EUR | 50.32% |
| 2022 Q1 | 2.3 Billion EUR | -50.71% |
| 2022 Q3 | 1.26 Billion EUR | -81.22% |
| 2022 Q4 | 7.02 Billion EUR | 455.21% |
| 2021 Q4 | 4.67 Billion EUR | 366.2% |
| 2021 FY | 4.67 Billion EUR | 26.11% |
| 2021 Q1 | 3.22 Billion EUR | -13.0% |
| 2021 Q2 | 6.82 Billion EUR | 111.66% |
| 2021 Q3 | 1 Billion EUR | -85.31% |
| 2020 FY | 3.7 Billion EUR | -7.81% |
| 2020 Q1 | 1.42 Billion EUR | -64.55% |
| 2020 Q2 | 5 Billion EUR | 250.77% |
| 2020 Q3 | 2.29 Billion EUR | -54.14% |
| 2020 Q4 | 3.7 Billion EUR | 61.64% |
| 2019 Q2 | 4.74 Billion EUR | 123.21% |
| 2019 Q1 | 2.12 Billion EUR | -32.21% |
| 2019 Q4 | 4.02 Billion EUR | 158.98% |
| 2019 FY | 4.02 Billion EUR | 28.38% |
| 2019 Q3 | 1.55 Billion EUR | -67.24% |
| 2018 Q4 | 3.13 Billion EUR | 93.87% |
| 2018 FY | 3.13 Billion EUR | 12.82% |
| 2018 Q2 | 3.31 Billion EUR | 70.63% |
| 2018 Q3 | 1.61 Billion EUR | -51.21% |
| 2018 Q1 | 1.94 Billion EUR | -30.1% |
| 2017 Q3 | 3.75 Billion EUR | 454.88% |
| 2017 FY | 2.77 Billion EUR | -15.13% |
| 2017 Q1 | 2.61 Billion EUR | -20.14% |
| 2017 Q2 | 676 Million EUR | -74.13% |
| 2017 Q4 | 2.77 Billion EUR | -25.97% |
| 2016 Q2 | 3.88 Billion EUR | -9.8% |
| 2016 Q1 | 4.3 Billion EUR | 7.76% |
| 2016 Q4 | 3.27 Billion EUR | -16.3% |
| 2016 FY | 3.27 Billion EUR | -18.08% |
| 2016 Q3 | 3.9 Billion EUR | 0.7% |
| 2015 Q1 | 4.11 Billion EUR | 84.58% |
| 2015 FY | 3.99 Billion EUR | 79.02% |
| 2015 Q2 | 4.54 Billion EUR | 10.37% |
| 2015 Q4 | 3.99 Billion EUR | -11.68% |
| 2015 Q3 | 4.52 Billion EUR | -0.51% |
| 2014 Q1 | 1.99 Billion EUR | 38.58% |
| 2014 FY | 2.23 Billion EUR | 55.36% |
| 2014 Q2 | 2.33 Billion EUR | 17.24% |
| 2014 Q3 | 2.59 Billion EUR | 11.14% |
| 2014 Q4 | 2.23 Billion EUR | -13.96% |
| 2013 Q2 | 2.1 Billion EUR | 36.98% |
| 2013 Q4 | 1.43 Billion EUR | -29.33% |
| 2013 Q1 | 1.53 Billion EUR | 119.43% |
| 2013 FY | 1.43 Billion EUR | 105.14% |
| 2013 Q3 | 2.03 Billion EUR | -3.42% |
| 2012 Q4 | 700 Million EUR | -52.19% |
| 2012 Q2 | 1.76 Billion EUR | 124.4% |
| 2012 Q1 | 787 Million EUR | 10.38% |
| 2012 Q3 | 1.46 Billion EUR | -17.1% |
| 2012 FY | 700 Million EUR | -1.82% |
| 2011 Q2 | 156 Million EUR | 135.7% |
| 2011 Q1 | -437 Million EUR | 62.81% |
| 2011 FY | 713 Million EUR | 160.68% |
| 2011 Q3 | 1.18 Billion EUR | 662.18% |
| 2011 Q4 | 713 Million EUR | -40.03% |
| 2010 Q3 | 80 Million EUR | -73.86% |
| 2010 FY | -1.17 Billion EUR | -887.39% |
| 2010 Q4 | -1.17 Billion EUR | -1568.75% |
| 2010 Q2 | 306 Million EUR | 313.51% |
| 2010 Q1 | 74 Million EUR | 162.18% |
| 2009 FY | -119 Million EUR | -120.95% |
| 2009 Q3 | 621 Million EUR | -26.07% |
| 2009 Q2 | 840 Million EUR | 57.3% |
| 2009 Q1 | 534 Million EUR | -0.74% |
| 2009 Q4 | -119 Million EUR | -119.16% |
| 2008 Q1 | 747.16 Million EUR | 114.31% |
| 2008 Q2 | 1.51 Billion EUR | 103.01% |
| 2008 Q3 | 1.49 Billion EUR | -1.34% |
| 2008 FY | 568 Million EUR | 110.88% |
| 2008 Q4 | 538 Million EUR | -64.05% |
| 2007 Q4 | -5.22 Billion EUR | -610.92% |
| 2007 Q2 | -2.45 Billion EUR | -24.43% |
| 2007 Q1 | -1.97 Billion EUR | 8.47% |
| 2007 FY | -5.22 Billion EUR | -142.33% |
| 2007 Q3 | 1.02 Billion EUR | 141.64% |
| 2006 FY | -2.15 Billion EUR | -167.43% |
| 2006 Q1 | 1.3 Billion EUR | 261.73% |
| 2006 Q3 | -3.35 Billion EUR | -267.08% |
| 2006 Q4 | -2.15 Billion EUR | 35.87% |
| 2006 Q2 | 2.01 Billion EUR | 54.33% |
| 2005 Q1 | 1.28 Billion EUR | 681.73% |
| 2005 Q4 | -805.47 Million EUR | -96805.85% |
| 2005 Q2 | 1.45 Billion EUR | 13.36% |
| 2005 FY | -805.47 Million EUR | -589.64% |
| 2005 Q3 | -831.19 Thousand EUR | -100.06% |
| 2004 Q4 | 164.5 Million EUR | -94.88% |
| 2004 Q2 | 3.7 Billion EUR | 22.35% |
| 2004 Q1 | 3.03 Billion EUR | 8.28% |
| 2004 FY | 164.5 Million EUR | -94.12% |
| 2004 Q3 | 3.21 Billion EUR | -13.36% |
| 2003 FY | 2.79 Billion EUR | -46.75% |
| 2003 Q4 | 2.79 Billion EUR | -46.54% |
| 2003 Q3 | 5.23 Billion EUR | -3.59% |
| 2003 Q2 | 5.43 Billion EUR | -2.32% |
| 2003 Q1 | 5.55 Billion EUR | 5.76% |
| 2002 Q1 | 7.21 Billion EUR | 3.28% |
| 2002 Q2 | 10.61 Billion EUR | 47.05% |
| 2002 Q3 | 10.42 Billion EUR | -1.75% |
| 2002 Q4 | 5.25 Billion EUR | -49.59% |
| 2002 FY | 5.25 Billion EUR | -24.78% |
| 2001 FY | 6.98 Billion EUR | 137.21% |
| 2001 Q4 | 6.98 Billion EUR | -6.77% |
| 2001 Q3 | 7.49 Billion EUR | 41.42% |
| 2001 Q2 | 5.3 Billion EUR | 18.06% |
| 2001 Q1 | 4.48 Billion EUR | 52.39% |
| 2000 Q3 | 1.71 Billion EUR | 329.97% |
| 2000 Q2 | -745.36 Million EUR | -205.07% |
| 2000 Q1 | 709.39 Million EUR | -28.04% |
| 2000 Q4 | 2.94 Billion EUR | 71.88% |
| 2000 FY | 2.94 Billion EUR | 198.85% |
| 1999 Q2 | -161.3 Million EUR | 95.0% |
| 1999 Q4 | 985.83 Million EUR | -40.31% |
| 1999 Q3 | 1.65 Billion EUR | 1123.96% |
| 1999 Q1 | -3.22 Billion EUR | -9.42% |
| 1999 FY | 985.83 Million EUR | 133.43% |
| 1998 FY | -2.94 Billion EUR | -214.84% |
| 1998 Q3 | 1.81 Billion EUR | -1.15% |
| 1998 Q2 | 1.83 Billion EUR | 31.72% |
| 1998 Q1 | 1.39 Billion EUR | -45.7% |
| 1998 Q4 | -2.94 Billion EUR | -262.42% |
| 1997 FY | 2.56 Billion EUR | -50.29% |
| 1997 Q4 | 2.56 Billion EUR | -43.76% |
| 1997 Q3 | 4.56 Billion EUR | -14.8% |
| 1997 Q2 | 5.35 Billion EUR | 7.22% |
| 1997 Q1 | 4.99 Billion EUR | -3.25% |
| 1996 Q4 | 5.16 Billion EUR | 0.0% |
| 1996 FY | 5.16 Billion EUR | 27.42% |
| 1995 Q4 | 4.05 Billion EUR | 0.0% |
| 1995 FY | 4.05 Billion EUR | -30.68% |
| 1994 FY | 5.84 Billion EUR | -9.35% |
| 1994 Q4 | 5.84 Billion EUR | 0.0% |
| 1993 FY | 6.45 Billion EUR | -41.75% |
| 1993 Q4 | 6.45 Billion EUR | 0.0% |
| 1992 Q4 | 11.07 Billion EUR | 0.0% |
| 1992 FY | 11.07 Billion EUR | 108.31% |
| 1991 FY | 5.31 Billion EUR | -18.18% |
| 1991 Q4 | 5.31 Billion EUR | 0.0% |
| 1990 FY | 6.49 Billion EUR | -39.81% |
| 1990 Q4 | 6.49 Billion EUR | 0.0% |
| 1989 Q4 | 10.79 Billion EUR | 0.0% |
| 1989 FY | 10.79 Billion EUR | -1.86% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Affluent Medical SA | 15.47 Million EUR | -37506.617% |
| Bluelinea Société Anonyme | -870.82 Thousand EUR | 668430.219% |
| Carmat SA | 49.63 Million EUR | -11625.361% |
| Diagnostic Medical Systems S.A. | 11.52 Million EUR | -50385.774% |
| Euromedis Groupe | -8.82 Million EUR | 66040.431% |
| Eurobio Scientific Société anonyme | 51.33 Million EUR | -11237.736% |
| Ikonisys S.A. | 3.19 Million EUR | -181883.109% |
| Implanet S.A. | 5.9 Million EUR | -98493.935% |
| Median Technologies SA | 3.5 Million EUR | -165901.141% |
| SpineGuard SA | 215.79 Thousand EUR | -2696879.105% |
| Theraclion SA | -5.86 Million EUR | 99340.605% |
| Euroapi S.A. | 191 Million EUR | -2947.12% |
| Guerbet SA | 332.59 Million EUR | -1649.892% |
| Ion Beam Applications SA | -67.72 Million EUR | 8693.831% |
| Sequana Medical NV | 14.2 Million EUR | -40877.809% |